Determining Bone strength measurement standards- comparing with existing standards to look for bone loss
Not Applicable
- Conditions
- Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Registration Number
- CTRI/2018/10/016060
- Lead Sponsor
- KASTURBA MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing a CT study which includes T12, L1 & L2 vertebrae at the request of their physician/ surgeon and are free of obvious bone pathology.
Exclusion Criteria
Genetic disorders
Hypogonadal states
Endocrine disorders
Gastrointestinal disorders
Hematologic disorders
Rheumatic and autoimmune disorders
On treatment for Depression
On treatment for Epilepsy
On chemotherapy
Chronic Diseases: metabolic diseases like hyper and hypothyroidism, Malabsorption syndromes
Long term drug intakes: - Of steroids /contraceptives/ chemotherapy
History of - Pregnancy within last 12 months or breastfeeding / Chronic immobilization / Joint problems like rheumatoid arthritis etc. / Use of any radio isotope for clinical investigation in the last one month
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The mean bone mineral density of local population along with the standard deviation can be compared to currently used UCSF standard which are being used in QCT BMD of phillips. <br/ ><br>Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method To estimate how much percentage of patients are wrongly diagnosed as osteoporosis when still in normal range when compared to local population referenceTimepoint: 1 year